amn adrenomyeloneuropathy glutathione Adrenoleukodystrophy To learn more, visit: https://www.clinicaltrials.gov/study/NCT05819866
To learn more, visit: https: www.clinicaltrials.gov study NCT05819866 A Clinical Study to Assess the Efficacy and Safety of Leriglitazone in Adult Male Subjects With Cerebral Adrenoleukodystrophy (CALYX) Sponsored by: Minoryx Therapeutics Nervonic acid, a long chain monounsaturated fatty acid, improves mitochondrial function in adrenomyeloneuropathy fibroblasts Li 2025 British Journal of Pharmacology Wiley Online Library Nineteen year follow up of a patient with severe glutathione synthetase deficiency Journal of Human Genetics Activation of sirtuin 1 as therapy for the peroxisomal disease adrenoleukodystrophy Cell Death & Differentiation
Pay in 4 interest-free payments of $7.06 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7


